CA Stock MarketDetailed Quotes

OMND Optimind Pharma Corp

Watchlist
  • 0.005
  • 0.0000.00%
15min DelayMarket Closed Jan 31 10:49 ET
548.94KMarket Cap-1.00P/E (TTM)

Optimind Pharma Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Nov 30, 2024
(Q2)Aug 31, 2024
(Q1)May 31, 2024
(FY)Feb 29, 2024
(Q4)Feb 29, 2024
(Q3)Nov 30, 2023
(Q2)Aug 31, 2023
(Q1)May 31, 2023
(FY)Feb 28, 2023
(Q4)Feb 28, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
266.20%12.17K
-50.87%-325.69K
148.14%117.41K
54.82%-470.27K
98.00%-3.18K
97.63%-7.32K
50.48%-215.88K
-77.35%-243.89K
-1.04M
-159.06K
Net income from continuing operations
91.34%-9.04K
55.01%-82.56K
75.85%-97.5K
54.60%-1.4M
64.41%-706.01K
67.02%-104.42K
71.75%-183.5K
-214.14%-403.66K
---3.08M
---1.98M
Depreciation and amortization
--0
--0
--0
-54.39%19.95K
--0
-54.39%4.99K
-31.58%7.48K
-31.58%7.48K
--43.74K
--10.94K
Asset impairment expenditure
----
----
----
-68.93%564.61K
----
----
----
----
--1.82M
----
Remuneration paid in stock
--0
--0
--0
--162.4K
--0
--0
--0
--162.4K
--0
--0
Deferred tax
----
----
----
1.02%-8.76K
----
----
----
----
---8.85K
---5.75K
Other non cashItems
----
----
----
-73.27%83.86K
-94.05%16.92K
-38.20%8.9K
219.55%28.97K
392.60%29.08K
--313.7K
--284.33K
Change In working capital
-74.51%21.21K
-253.23%-243.13K
648.34%214.91K
181.96%105.25K
770.55%130.07K
584.21%83.21K
0.34%-68.83K
-72.13%-39.19K
---128.41K
---19.4K
-Change in receivables
145.50%18.43K
-16.85%-27.35K
585.07%108.08K
57.88%-43.9K
92.20%-5.72K
132.37%7.51K
-252.56%-23.41K
3.66%-22.28K
---104.24K
---73.27K
-Change in payables and accrued expense
-96.32%2.79K
-375.05%-215.78K
731.71%106.83K
716.95%149.15K
152.05%135.78K
1,161.70%75.7K
46.19%-45.42K
-4,823.74%-16.91K
---24.18K
--53.87K
Cash from discontinued investing activities
Operating cash flow
266.20%12.17K
-50.87%-325.69K
148.14%117.41K
54.82%-470.27K
98.00%-3.18K
97.63%-7.32K
50.48%-215.88K
-77.35%-243.89K
---1.04M
---159.06K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
89.63%-22.86K
99.67%-212
55.44%-15.6K
95.94%-3.05K
91.21%-4K
-220.5K
-65K
Net business purchase and sale
--0
--0
--0
--0
-78.54%22.65K
55.44%-15.6K
95.94%-3.05K
91.21%-4K
---50K
--105.5K
Net other investing changes
----
----
----
86.59%-22.86K
----
----
----
----
---170.5K
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
89.63%-22.86K
99.67%-212
55.44%-15.6K
95.94%-3.05K
91.21%-4K
---220.5K
---65K
Financing cash flow
Cash flow from continuing financing activities
0
4.41%270K
0
32.53%-30.4K
0
-2,335.09%-277.6K
2,368.42%258.6K
-5.00%-11.4K
-45.06K
-11.4K
Net issuance payments of debt
--0
--0
--0
32.53%-30.4K
--0
33.33%-7.6K
0.00%-11.4K
0.00%-11.4K
---45.06K
---10.86K
Net common stock issuance
--0
----
----
----
----
---270K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
2,468.42%270K
--0
32.53%-30.4K
--0
33.33%-7.6K
0.00%-11.4K
-5.00%-11.4K
---45.06K
---11.4K
Net cash flow
Beginning cash position
44.42%90.41K
-50.12%146.1K
-94.80%28.7K
-70.29%552.22K
-95.93%32.08K
-94.52%62.6K
-82.41%292.93K
-70.29%552.22K
--1.86M
--787.68K
Current changes in cash
139.87%12.17K
75.82%-55.69K
145.28%117.41K
59.93%-523.52K
98.56%-3.39K
91.40%-30.52K
55.91%-230.33K
-33.74%-259.29K
---1.31M
---235.46K
End cash Position
219.73%102.58K
44.42%90.41K
-50.12%146.1K
-94.80%28.7K
-94.80%28.7K
-95.93%32.08K
-94.52%62.6K
-82.41%292.93K
--552.22K
--552.22K
Free cash from
266.20%12.17K
-50.87%-325.69K
148.14%117.41K
54.82%-470.27K
98.00%-3.18K
97.63%-7.32K
50.48%-215.88K
-77.35%-243.89K
---1.04M
---159.06K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Nov 30, 2024(Q2)Aug 31, 2024(Q1)May 31, 2024(FY)Feb 29, 2024(Q4)Feb 29, 2024(Q3)Nov 30, 2023(Q2)Aug 31, 2023(Q1)May 31, 2023(FY)Feb 28, 2023(Q4)Feb 28, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 266.20%12.17K-50.87%-325.69K148.14%117.41K54.82%-470.27K98.00%-3.18K97.63%-7.32K50.48%-215.88K-77.35%-243.89K-1.04M-159.06K
Net income from continuing operations 91.34%-9.04K55.01%-82.56K75.85%-97.5K54.60%-1.4M64.41%-706.01K67.02%-104.42K71.75%-183.5K-214.14%-403.66K---3.08M---1.98M
Depreciation and amortization --0--0--0-54.39%19.95K--0-54.39%4.99K-31.58%7.48K-31.58%7.48K--43.74K--10.94K
Asset impairment expenditure -------------68.93%564.61K------------------1.82M----
Remuneration paid in stock --0--0--0--162.4K--0--0--0--162.4K--0--0
Deferred tax ------------1.02%-8.76K-------------------8.85K---5.75K
Other non cashItems -------------73.27%83.86K-94.05%16.92K-38.20%8.9K219.55%28.97K392.60%29.08K--313.7K--284.33K
Change In working capital -74.51%21.21K-253.23%-243.13K648.34%214.91K181.96%105.25K770.55%130.07K584.21%83.21K0.34%-68.83K-72.13%-39.19K---128.41K---19.4K
-Change in receivables 145.50%18.43K-16.85%-27.35K585.07%108.08K57.88%-43.9K92.20%-5.72K132.37%7.51K-252.56%-23.41K3.66%-22.28K---104.24K---73.27K
-Change in payables and accrued expense -96.32%2.79K-375.05%-215.78K731.71%106.83K716.95%149.15K152.05%135.78K1,161.70%75.7K46.19%-45.42K-4,823.74%-16.91K---24.18K--53.87K
Cash from discontinued investing activities
Operating cash flow 266.20%12.17K-50.87%-325.69K148.14%117.41K54.82%-470.27K98.00%-3.18K97.63%-7.32K50.48%-215.88K-77.35%-243.89K---1.04M---159.06K
Investing cash flow
Cash flow from continuing investing activities 00089.63%-22.86K99.67%-21255.44%-15.6K95.94%-3.05K91.21%-4K-220.5K-65K
Net business purchase and sale --0--0--0--0-78.54%22.65K55.44%-15.6K95.94%-3.05K91.21%-4K---50K--105.5K
Net other investing changes ------------86.59%-22.86K-------------------170.5K----
Cash from discontinued investing activities
Investing cash flow --0--0--089.63%-22.86K99.67%-21255.44%-15.6K95.94%-3.05K91.21%-4K---220.5K---65K
Financing cash flow
Cash flow from continuing financing activities 04.41%270K032.53%-30.4K0-2,335.09%-277.6K2,368.42%258.6K-5.00%-11.4K-45.06K-11.4K
Net issuance payments of debt --0--0--032.53%-30.4K--033.33%-7.6K0.00%-11.4K0.00%-11.4K---45.06K---10.86K
Net common stock issuance --0-------------------270K----------------
Cash from discontinued financing activities
Financing cash flow --02,468.42%270K--032.53%-30.4K--033.33%-7.6K0.00%-11.4K-5.00%-11.4K---45.06K---11.4K
Net cash flow
Beginning cash position 44.42%90.41K-50.12%146.1K-94.80%28.7K-70.29%552.22K-95.93%32.08K-94.52%62.6K-82.41%292.93K-70.29%552.22K--1.86M--787.68K
Current changes in cash 139.87%12.17K75.82%-55.69K145.28%117.41K59.93%-523.52K98.56%-3.39K91.40%-30.52K55.91%-230.33K-33.74%-259.29K---1.31M---235.46K
End cash Position 219.73%102.58K44.42%90.41K-50.12%146.1K-94.80%28.7K-94.80%28.7K-95.93%32.08K-94.52%62.6K-82.41%292.93K--552.22K--552.22K
Free cash from 266.20%12.17K-50.87%-325.69K148.14%117.41K54.82%-470.27K98.00%-3.18K97.63%-7.32K50.48%-215.88K-77.35%-243.89K---1.04M---159.06K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.